The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Clinical Comparison of QUANTA Flash dsDNA Chemiluminescent Immunoassay with Four Current Assays for the Detection of Anti-dsDNA Autoantibodies
Open accessAbstract
Introduction . The objective of the present study was to compare QUANTA Flash dsDNA, a chemiluminescent immunoassay (CIA) on the BIO-FLASH, a rapid-response chemiluminescent analyzer, to three other anti-dsDNA antibody assays and to Crithidia luciliae indirect immunofluorescence test (CLIFT). Methods . In the first part of the study, 161 samples, 61 from patients suffering from systemic lupus erythematosus (SLE) and 100 from a disease control group, were tested by QUANTA Flash dsDNA CIA, QUANTA Lite dsDNA SC ELISA, BioPlex 2200 multiplex flow immunoassay (MFI), ImmuLisa dsDNA ELISA, and NOVA Lite CLIFT. A second cohort of 69 SLE patients was then tested by QUANTA Flash dsDNA and CLIFT to expand the study. Results . The overall qualitative agreements varied between 77.0% (NOVA Lite CLIFT versus QUANTA Lite) and 89.4% (ImmuLisa versus NOVA Lite CLIFT). The clinical sensitivities for the anti-dsDNA antibody tests varied from 8.2% (NOVA Lite CLIFT) to 54.1% (QUANTA Lite), while the clinical specificities varied from 88.0% (BioPlex 2200) to 100.0% (NOVA Lite CLIFT). Good correlation was found between QUANTA Flash dsDNA and NOVA Lite CLIFT. Conclusion . Significant variations among dsDNA methods were observed. QUANTA Flash dsDNA provides a good combination of sensitivity and specificity for the diagnosis of SLE and good agreement to CLIFT.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The specificities reported for CIA from INOVA Diagnostics (3 studies: 89.8%, 96.0%, 97.7% [60], [61], [67]) were higher than those reported from DiaSorin (2 studies: 82.9%, 84.9% [39], [47]), while the reported sensitivities for CIA from DiaSorin (78.6%, 84.6%) were higher than those reported from INOVA (20%, 39.9%, 54.3%) (Table 2).”
From Laboratory evaluation of anti-dsDNA antibodies. (2022) · cites this paper as [61]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“| INOVA Diagnostics | 96.0 [89.8-97.7] | 39.3 [20.0-54.3] | 60, 61, 67 | CIA |”
From Laboratory evaluation of anti-dsDNA antibodies. (2022) · cites this paper as [61]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“| INOVA Diagnostics | 96.0 [89.8-97.7] | 39.3 [20.0-54.3] | 60, 61, 67 | CIA |”
From Laboratory evaluation of anti-dsDNA antibodies. (2022) · cites this paper as [61]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“| Bio-rad Laboratories | 89.8 [86.7-96.9] | 59.4 [30.0-70.0] | 48, 60, 61, 64, 73 | Multiplex |”
From Laboratory evaluation of anti-dsDNA antibodies. (2022) · cites this paper as [61]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“| Bio-rad Laboratories | 89.8 [86.7-96.9] | 59.4 [30.0-70.0] | 48, 60, 61, 64, 73 | Multiplex |”
From Laboratory evaluation of anti-dsDNA antibodies. (2022) · cites this paper as [61]
Experimental — accuracy not yet measured
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cluster analysis and display of genome-wide expression patterns
Eisen, M. B., Spellman, P. T., Brown, P. O., & Botstein, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14863 · Cited by 16,184
The 1982 revised criteria for the classification of systemic lupus erythematosus
Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., Mcshane, D. J., Rothfield, N. F., Schaller, J. G., Talal, N., & Winchester, R. J. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780251101 · Cited by 14,519
Petri, M., Orbai, A., Alarcón, G. S., Gordon, C., Merrill, J. T., Fortin, P. R., Bruce, I. N., Isenberg, D., Wallace, D. J., Nived, O., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34473 · Cited by 5,322
Agmon-Levin, N., Damoiseaux, J., Kallenberg, C., Sack, U., Witte, T., Herold, M., Bossuyt, X., Musset, L., Cervera, R., Plaza-Lopez, A., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-203863 · Cited by 615
Epitope specificity and significance in systemic autoimmune diseases
Mähler, M., & Fritzler, M. J. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05127.x · Cited by 121
Shovman, O., Gilburd, B., Barzilai, O., Shinar, E., Larida, B., Zandman‐Goddard, G., Binder, S. R., & Shoenfeld, Y. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1313.120 · Cited by 115
Measurement of anti-DNA antibodies: a reappraisal using five different methods.
Isenberg, D. A., Dudeney, C., Williams, W., Addison, I. E., Charles, S., Clarke, J., & Todd-Pokropek, A. E. (1987) · Annals of the Rheumatic Diseases · doi:10.1136/ard.46.6.448 · Cited by 110
Beéck, K. O. D., Vermeersch, P., Verschueren, P., Westhovens, R., Mariën, G., Blockmans, D., & Bossuyt, X. (2012) · Autoimmunity Reviews · doi:10.1016/j.autrev.2012.02.013 · Cited by 108
Multiplexed AtheNA multi-lyte immunoassay for ANA screening in autoimmune diseases
Shovman, O., Gilburd, B., Zandman‐Goddard, G., Yehiely, A., Langevitz, P., & Shoenfeld, Y. (2005) · Autoimmunity · doi:10.1080/08916930400022707 · Cited by 75
Antico, A., Platzgummer, S., Bassetti, D., Bizzaro, N., Tozzoli, R., Villalta, D., & Study Group on Autoimmune Diseases of the Italian Society of Laboratory Medicine (SIMeL) (2010) · Lupus · doi:10.1177/0961203310362995 · Cited by 70
Research works printed but not linked: 1
- 2014, Journal of the Medical Association of Thailand: Chotmaihet thangphaet, 97, 220
Cited by
Chemiluminescent immunoassay technology: what does it change in autoantibody detection?
Cinquanta, L., Fontana, D. E., & Bizzaro, N. (2017) · Autoimmunity Highlights · doi:10.1007/s13317-017-0097-2 · Cited by 287
Autoantibodies Associated With Connective Tissue Diseases: What Meaning for Clinicians?
Didier, K., Bolko, L., Giusti, D., Toquet, S., Robbins, A., Antonicelli, F., & Servettaz, A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00541 · Cited by 187
Mummert, E., Fritzler, M. J., Sjöwall, C., Bentow, C., & Mahler, M. (2018) · Journal of Immunological Methods · doi:10.1016/j.jim.2018.05.014 · Cited by 86
Self-citationTrivedi, P. J., Tickle, J., Vesterhus, M. N., Eddowes, P. J., Bruns, T., Vainio, J., Parker, R., Smith, D., Liaskou, E., Thorbjørnsen, L. W., et al. (2017) · Gut · doi:10.1136/gutjnl-2016-312354 · Cited by 89
Detection of autoantibodies using chemiluminescence technologies
Mahler, M., Bentow, C., Serra, J., & Fritzler, M. J. (2016) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923973.2015.1077461 · Cited by 47
Metadata
- Authors
- Infantino, M., Meacci, F., Bentow, C., Martis, P., Benucci, M., Afeltra, A., Rigon, A., Atzeni, F., Sarzi-Puttini, P., Manfredi, M., & Mahler, M.
- Affiliations
- Nuovo Ospedale San Giovanni di Dio (IT)
- Inova Diagnostics, Inc., San Diego, CA 92131, USA
- Università Campus Bio-Medico (IT)
- Luigi Sacco Hospital (IT)
- UOC Reumatologia, Ospedale L. Sacco Polo Universitario, Via Giovanni Battista Grassi 74, 20157 Milano, Italy
- Corresponding author
- Infantino, Maria
- ORCID
- Venue
- Journal of Immunology Research
- Publisher
- Wiley
- Published
- 2015
- Volume
- 2015
- Pages
- 1-8
- ISSN
- 2314-7156 (ISSN-L)
- 2314-8861
- PMC
- PMC4352420
- OpenAlex
- W1991963925
- Semantic Scholar
- 5818f0de1377acb1b742ff592b5c1a41f47d13bb
- Cited by
- 41
- References
- 23
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 3 · 2023: 3 · 2022: 3 · 2021: 8 · 2020: 1 · 2018: 4 · 2017: 7 · 2016: 5 · 2015: 1
- FWCI
- 4.75
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Journal of Immunology Research (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Health Sciences › Medicine › Rheumatology › Vasculitis and related conditions
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Keywords
- anti-dsDNA antibodies, chemiluminescence immunoassay, systemic lupus erythematosus, ELISA, sensitivity and specificity, assay agreement
- MeSH terms
- Antibodies, Antinuclear, Fluorescent Antibody Technique, Humans, Lupus Erythematosus, Systemic, ROC Curve, Sensitivity and Specificity, Reproducibility of Results, Cluster Analysis, Case-Control Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clinical Comparison of QUANTA Flash dsDNA Chemiluminescent Immunoassay with Four Current Assays for the Detection of Anti-dsDNA Autoantibodies. https://app.cochat.ai/papers/10.1155/2015/902821
- The paper
- Infantino, M., Meacci, F., Bentow, C., Martis, P., Benucci, M., Afeltra, A., Rigon, A., Atzeni, F., Sarzi-Puttini, P., Manfredi, M., & Mahler, M. (2015). Clinical Comparison of QUANTA Flash dsDNA Chemiluminescent Immunoassay with Four Current Assays for the Detection of Anti-dsDNA Autoantibodies. Journal of Immunology Research. https://doi.org/10.1155/2015/902821
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.